The anti-GD2 therapy naxitamab has been included in the NCCN Clinical Practice Guidelines in Oncology for the treatment of ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...

The National Comprehensive Cancer Network (NCCN) policy summit highlighted the need for improved communication between ...

The National Comprehensive Cancer Network hosted an Oncology Policy Summit in Washington, D.C., today, focused on improving ...

A new survey by Johnson & Johnson revealed that oncologists are overwhelmed by the rapid pace of innovation in cancer care, ...

“We are very pleased with NCCN’s update of the NCCN Guidelines to include naxitamab-gggk (DANYELZA). We believe this decision reinforces the importance of naxitimab-gggk (DANYELZA) as a ...

NCCN publishes the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), which cover the latest evidence-based, expert consensus-driven recommendations for cancer screening ...

Daron Wells, a father of three and husband, has stage 4 lung cancer. He's now fighting for a possibly lifesaving procedure.

NCCN publishes the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ®), which cover the latest evidence-based, expert consensus-driven recommendations for cancer screening ...